145 related articles for article (PubMed ID: 19023518)
1. Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells.
Mueller T; Luetzkendorf J; Nerger K; Schmoll HJ; Mueller LP
Cell Mol Life Sci; 2009 Feb; 66(3):495-503. PubMed ID: 19023518
[TBL] [Abstract][Full Text] [Related]
2. Effect of ectopic high expression of transcription factor OCT4 on the "stemness" characteristics of human bone marrow-derived mesenchymal stromal cells.
Guo X; Tang Y; Zhang P; Li S; Chen Y; Qian B; Shen H; Zhao N
Stem Cell Res Ther; 2019 Jun; 10(1):160. PubMed ID: 31159871
[TBL] [Abstract][Full Text] [Related]
3. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
[TBL] [Abstract][Full Text] [Related]
4. Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity.
Mueller T; Mueller LP; Holzhausen HJ; Witthuhn R; Albers P; Schmoll HJ
Histochem Cell Biol; 2010 Aug; 134(2):197-204. PubMed ID: 20532795
[TBL] [Abstract][Full Text] [Related]
5. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene.
Lin H; Shabbir A; Molnar M; Lee T
Biochem Biophys Res Commun; 2007 Mar; 355(1):111-6. PubMed ID: 17280643
[TBL] [Abstract][Full Text] [Related]
6. Intercellular transport of Oct4 in mammalian cells: a basic principle to expand a stem cell niche?
Rolf HJ; Niebert S; Niebert M; Gaus L; Schliephake H; Wiese KG
PLoS One; 2012; 7(2):e32287. PubMed ID: 22359678
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines.
Western P; Maldonado-Saldivia J; van den Bergen J; Hajkova P; Saitou M; Barton S; Surani MA
Stem Cells; 2005; 23(10):1436-42. PubMed ID: 16166252
[TBL] [Abstract][Full Text] [Related]
8. Absence of OCT4 expression in somatic tumor cell lines.
Cantz T; Key G; Bleidissel M; Gentile L; Han DW; Brenne A; Schöler HR
Stem Cells; 2008 Mar; 26(3):692-7. PubMed ID: 18032701
[TBL] [Abstract][Full Text] [Related]
9. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
10. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells.
Greco SJ; Liu K; Rameshwar P
Stem Cells; 2007 Dec; 25(12):3143-54. PubMed ID: 17761754
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
12. Oct4 expression is not required for mouse somatic stem cell self-renewal.
Lengner CJ; Camargo FD; Hochedlinger K; Welstead GG; Zaidi S; Gokhale S; Scholer HR; Tomilin A; Jaenisch R
Cell Stem Cell; 2007 Oct; 1(4):403-15. PubMed ID: 18159219
[TBL] [Abstract][Full Text] [Related]
13. Role of Oct4 in maintaining and regaining stem cell pluripotency.
Shi G; Jin Y
Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
[TBL] [Abstract][Full Text] [Related]
14. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
15. Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells.
Yulin X; Lizhen L; Lifei Z; Shan F; Ru L; Kaimin H; Huang H
Folia Biol (Praha); 2012; 58(6):221-30. PubMed ID: 23438847
[TBL] [Abstract][Full Text] [Related]
16. Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells.
Koo BS; Lee SH; Kim JM; Huang S; Kim SH; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
Oncogene; 2015 Apr; 34(18):2317-24. PubMed ID: 24954502
[TBL] [Abstract][Full Text] [Related]
17. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.
Langenfeld E; Deen M; Zachariah E; Langenfeld J
Mol Cancer; 2013 Oct; 12(1):129. PubMed ID: 24160469
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid induces mouse bone marrow-derived CD15⁺, Oct4⁺ and CXCR4⁺ stem cells into male germ-like cells in a two-dimensional cell culture system.
Kashani IR; Zarnani AH; Soleimani M; Abdolvahabi MA; Nayernia K; Shirazi R
Cell Biol Int; 2014 Jun; 38(6):782-9. PubMed ID: 24677291
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
20. Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor.
Meng X; Su RJ; Baylink DJ; Neises A; Kiroyan JB; Lee WY; Payne KJ; Gridley DS; Wang J; Lau KH; Li G; Zhang XB
Cell Res; 2013 May; 23(5):658-72. PubMed ID: 23478301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
